Background Several clinical trials reported that clopidogrel was superior to aspirin in
secondary stroke prevention by reducing the risk of major adverse cardiovascular events …

Background Clopidogrel was thought to be superior to aspirin for secondary prevention of
vascular diseases in clinical trials. In this study we assessed the safety and efficacy of …

Aim Though combination of clopidogrel added to aspirin has been compared to aspirin
alone in patients with stroke or transient ischemic attack, limited data exists on the relative …

Objectives Despite large clinical trials, there is no consensus about the best antithrombotic
strategy for the secondary prevention of non-cardioembolic ischaemic stroke. This …

Objective There is insufficient evidence on which to base a recommendation for optimal
antiplatelet therapy following a stroke while on aspirin. The objective was to compare …

Background and Purpose Antiplatelet therapy is widely used for the primary or secondary
prevention of stroke. Drugs like clopidogrel have emerged as alternatives for traditional …

Background: Antiplatelet agents are the mainstay for secondary prevention of non-
cardioembolic stroke. This systematic review examined the safety and efficacy of short …

Background In real-world practice settings, there is insufficient evidence on the efficacy of
antiplatelet drugs, including clopidogrel, aspirin, and ticlopidine, in stroke prevention …

Background In patients with ischemic stroke of non-cardioembolic origin, acetylsalicylic acid,
clopidogrel, or a combination of acetylsalicylic acid and dipyridamole are recommended for …

Objectives Whether clopidogrel should be added to aspirin for stroke prevention remained
controversial for the risk of hemorrhagic complications. This meta-analysis was aimed to …